Feb 19 (Reuters) - Cochlear Ltd (COH) :
- SEES FY21 UNDERLYING NET PROFIT GUIDANCE OF $225‐245M
- IN SECOND HALF, EXPECT DEVELOPED MARKETS TO DELIVER SIMILAR CI UNITS TO FIRST HALF
- CAPITAL EXPENDITURE IS EXPECTED TO BE AROUND $70 MILLION FOR FY21 AND IN RANGE OF $60‐80 MILLION FOR FY22
- IN FIRST SIX WEEKS OF 2021, CI UNITS WERE DOWN MODESTLY ON LAST YEAR
- SEES STRENGTHENING AUSTRALIAN DOLLAR IS EXPECTED TO HAVE A MATERIAL IMPACT ON SECOND HALF NET PROFIT
- UK CONTINUES TO BE MOST AFFECTED WITH MAJORITY OF CLINICS NOW LIMITED TO EMERGENCY PROCEDURES ONLY
- LEVEL OF HEDGING IN PLACE FOR FY21 IS LOWER THAN NORMAL DUE TO COVID‐RELATED UNCERTAINTY OF CASHFLOWS
- COMMITTED TO MAINTAINING DIVIDEND POLICY WHICH TARGETS 70% PAYOUT OF UNDERLYING NET PROFIT
- Forums
- ASX - By Stock
- COH
- News: COH Cochlear Sees FY21 Underlying Net Profit Guidance Of $225‐245M
COH
cochlear limited
Add to My Watchlist
0.70%
!
$303.78

News: COH Cochlear Sees FY21 Underlying Net Profit Guidance Of $225‐245M
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$303.78 |
Change
2.120(0.70%) |
Mkt cap ! $19.86B |
Open | High | Low | Value | Volume |
$303.79 | $304.22 | $300.12 | $51.31M | 169.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 77 | $302.32 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$304.30 | 100 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 77 | 302.320 |
1 | 57 | 300.680 |
1 | 18 | 300.500 |
1 | 38 | 300.140 |
5 | 705 | 300.000 |
Price($) | Vol. | No. |
---|---|---|
304.300 | 100 | 1 |
304.440 | 50 | 1 |
304.620 | 250 | 1 |
304.800 | 330 | 1 |
304.950 | 5 | 1 |
Last trade - 16.10pm 21/08/2025 (20 minute delay) ? |
Featured News
COH (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, MD & CEO
Michael Thurn
MD & CEO
SPONSORED BY The Market Online